Ingevity (NGVT) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Ingevity reports third quarter 2023 financial results
November 1, 2023 4:15 PM EDTHIGHLIGHTS: (comparisons versus prior year period)
Net sales of $446.0 million, down 7%, compared to a record prior year Net income of $25.2 million and diluted earnings per share (EPS) of $0.69; adjusted earnings of $44.2 million and diluted adjusted EPS of $1.21 Adjusted EBITDA of $110.4 million and adjusted EBITDA margin of 24.8% Operating cash flow of $106.9 million with free cash flow of $73.4 million Updated 2023 full-year guidance for adjusted EBITDA between $375 million to $390 million The company also announced today actions to accelerate the repositioning of its Performance Chemicals segment, including the closure of its DeRidder, Louisiana,... More